BRSF (BRSF) Stock Price & Analysis
BRSF (BRSF) rose 0.00% to USD 0 as of June 10, 2026 at 03:32 UTC, according to Nexqual real-time market data.
BRSF last closed at USD 0; the session ranged USD 0–0 on volume of 108 shares. Market capitalization is $745, with a 52-week range of USD 0–0.75 (PNK). Source: Nexqual, June 10, 2026 at 03:32 UTC.
Key Statistics (as of June 10, 2026 at 03:32 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0.75 |
| Volume | 108 shares |
| Market Cap | $745 |
| Exchange | PNK |
Technical Analysis (BRSF)
Nexqual's technical model rates BRSF "BUY" based on 5 bullish and 2 bearish signals across 124 daily candles, as of June 10, 2026 at 03:32 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Above (USD 0) |
| MACD | 0 (positive) |
Analyst Ratings (BRSF)
Wall Street analysts rate BRSF "None", per Nexqual as of June 10, 2026 at 03:32 UTC.
| Consensus Rating | None |
|---|
Earnings (BRSF)
Source: Nexqual, June 10, 2026 at 03:32 UTC.
Financials & Fundamentals (BRSF)
| Total Revenue | $214,564 |
|---|---|
| Revenue Growth (YoY) | -98.00% |
| Gross Margin | +25.32% |
| Operating Margin | -29590.79% |
| Profit Margin | +0.00% |
| ROE | -681.55% |
| Debt / Equity | 66.33 |
| Current Ratio | 0.18 |
| Total Cash | $747,714 |
| Total Debt | $2.86M |
| Free Cash Flow | $-208,386 |
Source: Nexqual, June 10, 2026 at 03:32 UTC.
Financial Health Score (BRSF)
Nexqual rates BRSF's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 03:32 UTC.
| Growth | Critical — Revenue -98% YoY (latest Q), sharp decline |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Mixed — $748K cash vs $3M debt |
| Cash Flow | Weak — FCF negative: -$208K, burning cash |
| Efficiency | Critical — ROE -682%, ROA -47.8% |
Ownership (BRSF)
| Insider Ownership | +29.34% |
|---|---|
| Institutional Ownership | +30.64% |
| Shares Outstanding | 1.24M |
| Float | 497,270 |
Source: Nexqual, June 10, 2026 at 03:32 UTC.
Leadership (BRSF)
BRSF is led by Hassan Kotob (age 60), CEO & Chairman, per Nexqual as of June 10, 2026 at 03:32 UTC.
| CEO & Chairman | Hassan Kotob (age 60) |
|---|---|
| Chief Revenue Officer & Director | Daniel Cloutier (age 59) |
| President of Piezo Motion Corp. | Mark P. Broderick |
| Vice President of Marketing & Communications | Kevin Winterfield |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| NMTRQ | 9 Meters Biopharma, Inc. | USD 0 | ▲ 0% |
| TBBA | TEB Bancorp Inc. | USD 6.5 | ▼ 0.31% |
| GMVDF | G Medical Innovations Holdings | USD 0 | ▲ 0% |
| AILQF | AirIQ Inc. | USD 0.37 | ▲ 0% |
| EAWD | Energy and Water Development Co | USD 0.01 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 03:32 UTC. This page is informational and not investment advice.